Haloperidol antagonism of cue-elicited cocaine craving

Lancet

Volumn 347, Issue 9000, 1996, Pages 504-508

  Berger, S Paul ^a,c,e   Hall, Stephen ^b   Mickalian, Joanne D ^c   Reid, Malcolm S ^a,c   Crawford, Cynthia A ^d   Delucchi, Kevin ^a,c   Carr, Kirkland ^f   Hall, Sharon ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^c S Francisco Vet Aff Med Center   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^f NONE

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; CORTICOTROPIN; DOPAMINE; HALOPERIDOL; HOMOVANILLIC ACID; HYDROCORTISONE; NEUROLEPTIC AGENT;

ADOLESCENT; ADULT; ANXIETY; ARTICLE; ASSOCIATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONDITIONING; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOPAMINE RELEASE; HUMAN; MALE; NARCOTIC DEPENDENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0030063895     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)91139-3     Document Type: Article

References (26)

1. Gawin FH, Kleber HD. Abstinence symptomatology and psychiatric diagnosis in cocaine abusers. Clinical observations. Arch Gen Psychiatry 1986; 43: 107-13.
2. O'Brien CP, Childress AR, McLellan T, Ehrman R. Integrating systemic cue exposure with standard treatment in recovering drug dependent patients. Addict Behav 1990; 15: 355-65.
3. Childress AR, McLellan AT, O'Brien CP. Abstinent opiate abusers exhibit conditioned craving, conditioned withdrawal and reductions in both through extinction. Br J Addiction 1986; 81: 655-60.
4. Childress AR, Hole AV, Ehrman RN, Robbins SJ, McLellan AT, O'Brien CP. Cue reactivity and cue reactivity interventions in drug dependence. Nida Res Monogr 1993; 137: 73-95.
5. Kuhar MJ, Ritz MC, Boja JW. The dopamine hypothesis of the reinforcing properties of cocaine. Trends Neurosci 1991; 14: 299-302.
6. Dackis CA, Gold MS, Sweeney DR, Byron JJ, Climko R. Single-dose bromocriptine reverses cocaine craving. Psychiatry Res 1987; 20: 261-64.
7. Kranzler HR, Bauer LO. Bromocriptine and cocaine cue reactivity in cocaine-dependent patients. Br J Addiction 1992; 87: 1537-48.
8. Margolin A, Kosten T, Petrakis I, Avants SK, Kosten T. Bupropion reduces cocaine abuse in methadone-maintained patients. Arch Gen Psychiatry 1991; 48: 87.
9. Robbins SJ, Ehrman RN, Childress AR, O'Brien CP. Using cue reactivity to screen medications for cocaine abuse: a test of amantadine hydrochloride. Addict Behav 1992; 17: 491-99.
10. Kalivas PW, Duffy P. Effect of acute and daily cocaine treatment on extracellular dopamine in the nucleus accumbens. Synapse 1990; 5: 48-58.
11. Fontana DJ, Post RM, Pert A. Conditioned increases in mesolimbic dopamine overflow by stimuli associated with cocaine. Brain Res 1993; 629: 31-39.
12. Robinson TE, Berridge KC. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Rev 1993; 18: 247-91.
13. Amin F, Davidson M, Davis KL. Homovanillic acid measurement in clinical research: a review of methodology. Schizophr Bull 1992; 18: 123-48.
14. Martin SD, Yeragani VK, Lodhi R, Galloway MP. Clinical ratings and plasma HVA during cocaine abstinence. Biol Psychiatry 1989; 26: 356-62.
15. Knoblich G, Curtis D, Faustman WO, et al. Increased CSF HVA with craving in long-term abstinent cocaine abusers. Biol Psychiatry 1992: 32: 96-100.
16. Pleim ET, Matochik JA, Barfield RJ, Auerbach SB. Correlation of dopamine release in the nucleus accumbens with masculine sexual behavior in rats. Brain Res 1990; 524: 160-63.
17. Breier A, Davis O, Buchanan R, et al. Effects of alprazolam on pituitary-adrenal and catecholaminergic responses to metabolic stress in humans. Biol Psychiatry 1992; 32: 880-90.
18. Farde L, Nordstrom AL, Wiesel FA, Pauli S, Halldin C, Sedvall G. Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects. Arch Gen Psychiatry 1992; 49: 538-44.
19. McLellan AT, Luborsky L, Woody GE, O'Brien CP. An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index. J Nerv Ment Dis 1980; 168: 26-33.
20. Chang WH, Scheinin M, Burns RS, Linnoila M. Rapid and simple determination of homovanillic acid in plasma using high performance liquid chromatography with electrochemical detection. Acta Pharmacol Toxicol (Copenh) 1983; 53: 275-79.
21. Nicholson WE, Davis DR, Sherrell BJ, Orth DN. Rapid radioimmunoassay for corticotropin in unextracted human plasma. Clin Chem 1984; 30: 259-65.
22. Seeman P, Van TH. Dopamine receptor pharmacology. Trends Pharmacol Sci 1994; 15: 264-70.
23. Parsons LH, Smith AD, Justice JJ. Basal extracellular dopamine is decreased in the rat nucleus accumbens during abstinence from chronic cocaine. Synapse 1991; 9: 60-65.
24. Childress AR, McLellan AT, Natale M, O'Brien CP. Mood states can elicit conditioned withdrawal and craving in opiate abuse patients. Nida Res Monogr 1987; 76: 137-44.
25. Leyton M, Rajabi H, Stewart J. U-50,488H into A10 reduces haloperidol-induced elevations of accumbens dopamine. Neuroreport 1992; 3: 1127-30.
26. Crawford CA, McDougall SA, Bolanos CA, Hall S, Berger SP. The effects of the kappa agonist U-50,488 on cocaine-induced conditioned and unconditioned behaviors and fos immunoreactivity. Psychopharmacology 1995; 120: 392-99.